CCI Approves Bain Capital-Linked Acquisition of Omega-Meyer and Meyer Organics

The Competition Commission of India (CCI) has approved the acquisition of sole control over Omega-Meyer Limited and Meyer Organics Private Limited by BCPE Wellbeing Holdco Two Limited and Integral Investments Asia IV Limited.

Bain Capital-Managed Funds as Acquirers

The two acquiring entities are funds managed and/or advised by Bain Capital Investors, LLC, a US-based private equity investment firm. The acquisition is being undertaken through BCPE Wellbeing Holdco Two Limited and Integral Investments Asia IV Limited.

The proposed combination involves the acquisition of sole control over Omega-Meyer Limited and Meyer Organics Private Limited, which own and control groups of companies and affiliates operating under the names ‘Vitabiotics’ and ‘Meyer Organics’, respectively.

Business Activities of the Parties

Bain Capital invests in companies across industries including information technology, healthcare, retail and consumer products, communications, financial services, and industrial/manufacturing.

Omega-Meyer Limited and Meyer Organics Private Limited are engaged in the provision of nutraceuticals globally and in India.

Meyer Organics also has a presence in the production and supply of certain over-the-counter and prescription finished-dose pharmaceuticals in India.